Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Vir Biotechnology Names Aziz Sawaf as CFO

Vir Biotechnology Names Aziz Sawaf as CFO

MT newswireMT newswire2026/10/01 13:07
09:07 AM EDT, 10/01/2026 (MT Newswires) -- Vir Biotechnology (VIR) said Thursday it has appointed Aziz Sawaf as chief financial officer, starting Oct. 5. Sawaf succeeds Brent Sabatini as the company's principal financial officer, Vir said in a filing with the US Securities and Exchange Commission. Sabatini will continue in his role as chief accounting officer, the company said. In July, the company said Jason O'Byrne was resigning as CFO, effective Aug. 3, to pursue another opportunity, and that it appointed Sabatini as interim principal financial officer. Sawaf joins Vir from Theravance Biopharma, where he served as CFO, the company added.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Precia reports 5,733,040 issued shares, 8,350,574 exercisable voting rights as of Aug. 31, 2026

Precia disclosed 5,733,040 issued shares as of Aug. 31, 2026. Theoretical voting rights totaled 8,677,204. Exercisable voting rights stood at 8,350,574, reflecting 326,630 treasury shares without voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precia SA published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/06 15:14